• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020年至2023年加拿大采用不同招募策略的新冠病毒血清学监测研究的社会人口学特征

Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023.

作者信息

Knight Matthew J, Yu Yuan, Chen Jiacheng, O'Brien Sheila F, Buckeridge David L, Charlton Carmen, Russell W Alton

机构信息

Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada.

Canadian Blood Services, Ottawa, Canada.

出版信息

BMC Public Health. 2025 Jun 3;25(1):2057. doi: 10.1186/s12889-025-22975-y.

DOI:10.1186/s12889-025-22975-y
PMID:40462073
Abstract

BACKGROUND

Serological testing was a key component of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) surveillance. Social distancing interventions, resource limitations, and the need for timely data led to serosurveillance studies using a range of recruitment strategies, which likely influenced study representativeness. Characterizing representativeness in surveillance is crucial to identify gaps in sampling coverage and to assess health inequities.

METHODS

We retrospectively analyzed three pre-existing longitudinal cohorts, two convenience samples using residual blood, and one de novo probabilistic survey conducted in Canada between April 2020 - November 2023. We calculated study specimen counts by age, sex, urbanicity, race/ethnicity, and neighborhood deprivation quintiles. We derived a 'representation ratio' as a simple metric to assess generalizability to a target population and various sociodemographic strata.

RESULTS

The six studies included 1,327,142 specimens. When stratifying by age group and sex, 67% of racialized minority subgroups were moderately underrepresented (representation ratio < 0.75). Representation was generally higher for older Canadians, urban neighborhoods, and neighborhoods with low material deprivation. Rural representation was highest in a study that used outpatient laboratory blood specimens. Racialized minority representation was highest in a de novo probabilistic survey cohort and an open longitudinal cohort recruited from an online polling panel.

CONCLUSION

While no study had adequate representation of all subgroups, less traditional recruitment strategies were more representative of some population dimensions. Understanding demographic representativeness and barriers to recruitment are important considerations when designing population health surveillance studies.

摘要

背景

血清学检测是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)监测的关键组成部分。社交距离干预措施、资源限制以及对及时数据的需求导致血清学监测研究采用了一系列招募策略,这可能影响了研究的代表性。在监测中描述代表性对于识别抽样覆盖范围的差距和评估健康不平等至关重要。

方法

我们回顾性分析了三个现有的纵向队列、两个使用剩余血液的便利样本以及2020年4月至2023年11月在加拿大进行的一项全新概率调查。我们按年龄、性别、城市化程度、种族/族裔以及邻里贫困五分位数计算了研究样本数量。我们得出了一个“代表性比率”作为一个简单指标,以评估对目标人群和各个社会人口阶层的可推广性。

结果

这六项研究包括1327142个样本。按年龄组和性别分层时,67%的少数族裔亚组代表性中度不足(代表性比率<0.75)。加拿大老年人、城市社区以及物质匮乏程度低的社区的代表性通常更高。在一项使用门诊实验室血液样本的研究中,农村地区的代表性最高。在一项全新概率调查队列和一个从在线投票小组招募的开放纵向队列中,少数族裔的代表性最高。

结论

虽然没有一项研究能充分代表所有亚组,但较少传统的招募策略在某些人群维度上更具代表性。在设计人群健康监测研究时,了解人口代表性和招募障碍是重要的考虑因素。

相似文献

1
Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023.2020年至2023年加拿大采用不同招募策略的新冠病毒血清学监测研究的社会人口学特征
BMC Public Health. 2025 Jun 3;25(1):2057. doi: 10.1186/s12889-025-22975-y.
2
Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.2020 年 7 月至 8 月,科罗拉多州丹佛市通过社区调查和剩余标本评估 SARS-CoV-2 血清流行率。
Public Health Rep. 2022 Jan-Feb;137(1):128-136. doi: 10.1177/00333549211055137. Epub 2021 Nov 9.
3
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.加拿大第一波 COVID-19 疫情后献血者中的 SARS-CoV-2 血清流行率。
Transfusion. 2021 Mar;61(3):862-872. doi: 10.1111/trf.16296. Epub 2021 Feb 23.
4
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.加拿大蒙特利尔地区学校和日托中心儿童中 SARS-CoV-2 抗体的血清阳性率。
JAMA Netw Open. 2021 Nov 1;4(11):e2135975. doi: 10.1001/jamanetworkopen.2021.35975.
5
Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study.澳大利亚维多利亚州按年龄和疫苗接种状况对 COVID-19 病例进行差异判定:血清学监测和记录链接研究。
Commun Dis Intell (2018). 2024 Aug 21;48. doi: 10.33321/cdi.2024.48.28.
6
Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.2020 年和 2021 年加拿大成年人中 SARS-CoV-2 血清阳性率在第一波和第二波疫情期间的评估。
JAMA Netw Open. 2022 Feb 1;5(2):e2146798. doi: 10.1001/jamanetworkopen.2021.46798.
7
Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors.加拿大献血者中 COVID-19 血清阳性率差异的时间趋势。
Int J Epidemiol. 2024 Apr 11;53(3). doi: 10.1093/ije/dyae078.
8
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.2020 年 4 月至 11 月英国 SARS-CoV-2 社区流行率:来自 ONS 冠状病毒感染调查的结果。
Lancet Public Health. 2021 Jan;6(1):e30-e38. doi: 10.1016/S2468-2667(20)30282-6. Epub 2020 Dec 11.
9
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
10
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.COVID-19 大流行开始一年后接受透析的美国患者中估计的 SARS-CoV-2 血清流行率。
JAMA Netw Open. 2021 Jul 1;4(7):e2116572. doi: 10.1001/jamanetworkopen.2021.16572.

本文引用的文献

1
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study.加拿大成年人中严重急性呼吸综合征冠状病毒 2 感染和疫苗接种产生的混合免疫:一项队列研究。
Elife. 2024 Jun 25;13:e89961. doi: 10.7554/eLife.89961.
2
Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors.加拿大献血者中 COVID-19 血清阳性率差异的时间趋势。
Int J Epidemiol. 2024 Apr 11;53(3). doi: 10.1093/ije/dyae078.
3
Design and Implementation of a National Program to Monitor the Prevalence of SARS-CoV-2 IgG Antibodies in England Using Self-Testing: The REACT-2 Study.
利用自我检测监测英格兰地区 SARS-CoV-2 IgG 抗体流行率的国家项目的设计与实施:REACT-2 研究。
Am J Public Health. 2023 Nov;113(11):1201-1209. doi: 10.2105/AJPH.2023.307381. Epub 2023 Sep 21.
4
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.2021 年 4 月至 2022 年 9 月期间,按 COVID-19 疫苗接种状况划分的献血者中 SARS-CoV-2 血清流行率和原发性 SARS-CoV-2 感染发生率估计值-美国。
MMWR Morb Mortal Wkly Rep. 2023 Jun 2;72(22):601-605. doi: 10.15585/mmwr.mm7222a3.
5
Defining representativeness of study samples in medical and population health research.界定医学与人群健康研究中样本的代表性。
BMJ Med. 2023 May 16;2(1):e000399. doi: 10.1136/bmjmed-2022-000399. eCollection 2023.
6
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.监测新冠疫情:德国一项针对献血者的大型重复性横断面研究中抗体的流行情况——SeBluCo研究(2020 - 2022年)结果
Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551.
7
Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.加拿大使用产前血清样本的 SARS-CoV-2 血清学调查:一项回顾性血清流行率研究。
CMAJ Open. 2023 Apr 4;11(2):E305-E313. doi: 10.9778/cmajo.20220045. Print 2023 Mar-Apr.
8
SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE-COVID Study.西班牙第一波和第二波大流行期间的 SARS-CoV-2 感染:ENE-COVID 研究。
Am J Public Health. 2023 May;113(5):533-544. doi: 10.2105/AJPH.2023.307233. Epub 2023 Mar 9.
9
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.基于健康社会决定因素的全加 SARS-CoV-2 血清流行率的血液捐赠者的跨加拿大变异性。
Microbiol Spectr. 2023 Feb 14;11(1):e0335622. doi: 10.1128/spectrum.03356-22. Epub 2023 Jan 10.
10
Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.2020 年和 2021 年加拿大成年人中 SARS-CoV-2 血清阳性率在第一波和第二波疫情期间的评估。
JAMA Netw Open. 2022 Feb 1;5(2):e2146798. doi: 10.1001/jamanetworkopen.2021.46798.